Back to Search
JOHN DEEKEN, MD
MD
Medical Oncology Physician
NPI: 1659390755IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
036169(DC)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
0101235487(VA)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE
Class of 2001
Research & Publications (12)
Identification of compounds that correlate with ABCG2 transporter function in the National Cancer Institute Anticancer Drug Screen.
PMID 19633067·Mol Pharmacol·2009
4-observational
Targeted therapies to treat non-AIDS-defining cancers in patients with HIV on HAART therapy: treatment considerations and research outlook.
PMID 19606034·Curr Opin Oncol·2009
6-review
The Affymetrix DMET platform and pharmacogenetics in drug development.
PMID 19479659·Curr Opin Mol Ther·2009
6-review
The 315-316 deletion determines the BXP-21 antibody epitope but has no effect on the function of wild type ABCG2 or the Q141K variant.
PMID 19002564·Mol Cell Biochem·2009
8-other
Irinotecan and uridine diphosphate glucuronosyltransferase 1A1 pharmacogenetics: to test or not to test, that is the question.
PMID 18720361·Cancer·2008
6-review
ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel.
PMID 18628469·Clin Cancer Res·2008
8-other
The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.
PMID 17363519·Clin Cancer Res·2007
6-review
ABCG2: determining its relevance in clinical drug resistance.
PMID 17323127·Cancer Metastasis Rev·2007
6-review
Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
PMID 17159598·Anticancer Drugs·2007
6-review
Immunologic therapies for gastrointestinal cancers.
PMID 15929805·Clin Colorectal Cancer·2005
6-review
Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor.
PMID 15528978·Invest New Drugs·2005
3-trial
Care for the caregivers: a review of self-report instruments developed to measure the burden, needs, and quality of life of informal caregivers.
PMID 14527761·J Pain Symptom Manage·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 8081 INNOVATION PARK DR
FAIRFAX, VA 22031 - Phone
- (571) 472-4724
Quick Facts
- NPI
- 1659390755
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 25
- Publications
- 12
Are you this provider?
Claim Your Profile